Eton Pharmaceuticals FY2026 Revenue expected to be more than $175.000M vs $149.702M Est

Benzinga · 10h ago
Eton Pharmaceuticals (NASDAQ:ETON) FY2026 Revenue expected to be more than $175.000M vs $149.702M Est